Mivacurium for caesarean section in hypertensive parturients receiving magnesium sulphate therapy

International Journal of Obstetric Anesthesia

Volumn 7, Issue 1, 1998, Pages 12-17

  Hodgson, R E ^a,b   Rout, C C ^a,b   Rocke, D A ^a,b   Louw, N J ^a,b  

^a UNIVERSITY OF KWAZULU NATAL   (South Africa)

^b Department of Anaesthesia ^*  (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ALFENTANIL; CHOLINESTERASE; MAGNESIUM ION; MAGNESIUM SULFATE; MIVACURIUM; NEUROMUSCULAR BLOCKING AGENT; SUXAMETHONIUM;

ADULT; ANESTHESIA INDUCTION; ARTICLE; CESAREAN SECTION; CHOLINESTERASE BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ELECTROMYOGRAPHY; FEMALE; GENERAL ANESTHESIA; HUMAN; HYPERTENSION; MAGNESIUM BLOOD LEVEL; NEUROMUSCULAR FUNCTION;

EID: 0031984338     PISSN: 0959289X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-289X(98)80022-8     Document Type: Article

References (17)

1. Sibai B M. Magnesium sulfate is the ideal anticonvulsant in preeclampsia-eclampsia. Am J Obstet Gynecol 1990; 162: 1141-1145.
2. Ashton W B, James M F M, Janicki P, Uys P C. Attenuation of the pressor response to tracheal intubation by magnesium sulphate with and without alfentanil in hypertensive proteinuric patients undergoing caesarean section. Br J Anaesth 1991; 67: 741-747.
3. Sinatra R S, Philip B K, Naulty J S, Ostheimer G W. Prolonged neuromuscular blockade with vecuronium in a patient treated with magnesium sulfate. Anesth Analg 1985; 64: 1220-1222.
4. Baraka A, Yazigi A. Neuromuscular interaction of magnesium with succinylcholine-vecuronium sequence in the eclamptic parturient. Anesthesiology 1987; 67: 806-808.
5. Crawford J S, Lewis M, Davies P. Maternal and neonatal responses related to the volatile agent used to maintain anaesthesia at caesarean section. Br J Anaesth 1985; 57: 482-487.
6. Mirakhur R K. Newer neuromuscular blocking drugs. An overview of their clinical pharmacology and therapeutic use. Drugs 1992; 44: 182-199.
7. Lucas M J, Leveno K J, Cunningham F G. A comparison of magnesium sulfate with phenytoin for the prevention of eclampsia. New Engl J Med 1995; 333: 201-205.
8. The Eclampsia Trial Collaborative Group. Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia Trial. Lancet 1995; 345: 1455-1463.
9. Allen R W, James M F M, Uys P C. Attenuation of the pressor response to tracheal intubation in hypertensive proteinuric pregnant patients by lignocaine, alfentanil and magnesium sulphate. Br J Anaesth 1991; 66: 216-223.
10. Maddineni V R, Mirakhur R K, McCoy E P. Recovery of mivacurium block with or without anticholinesterases following administration by continuous infusion. Anaesthesia 1994; 49: 946-948.
11. Engbæk J, Ostergaard D, Viby-Mogensen J, Skovgaard L T. Clinical recovery and train-of-four ratio measured mechanically and electromyographically following atracurium. Anesthesiology 1989; 71: 391-395.
12. Viby Mogensen J, Engbæk J, Eriksson L I et al. Good Clinical Research Practice (GCRP) in pharmacodynamic studies of neuromuscular blocking agents. Acta Anaesthesiol Scand 1996; 40: 59-74.
13. Lee C, Nguyen N B, Tran B K, Katz R. Quantification of magnesium-pancuronium interaction in the diaphragm and tibialis anterior. Anesthesiology 1982; 57: A392.
14. Sockalingam I, Green D W. Mivacurium-induced prolonged neuromuscular block. Br J Anaesth 1995; 74: 234-236.
15. Ghoneim M M, Long J P. The interaction between magnesium and other neuromuscular blocking agents. Anesthesiology 1970; 32: 23-27.
16. Naguib M, Abdulatif M, Selim M, Al-Ghamdi A. Dose-response studies of the interaction between mivacurium and suxamethonium. Br J Anaesth 1995; 74: 26-30.
17. Erkola O, Rautoma P, Meretoja OA. Interaction between mivacurium and succinycholine. Anesth Analg 1995; 80: 534-537.